1. SHP:LSE

    Shire PLC

    GBp

    4,261

    Today's change

    74.00 / +1.77%

    1 year change

    -19.45%

    As of Apr 29 2016 17:10 BST. Data delayed by at least 15 minutes.

Search for Shire PLC and
  1. 13 hours ago

    Shire chief shrugs off shareholder protests

    Shire chief executive Flemming Ornskov brushed off shareholder protests against his $21.6m pay package even as the...

  2. Fast FT

    21 hours ago

    Shire 'off to strong start in 2016'

    Maybe Flemming Ornskov was worth his $21m pay packet after all. A day after almost half of Shire shareholders voted...

Special Reports

  1. Combating Rare Diseases

    For decades, rare diseases were all but ignored by the pharmaceuticals industry. That ...
Search more Special Reports on this topic.

  1. Fast FT

    April 29, 2016

    WPP boss receives £70m pay package

    Sir Martin Sorrell has received £70m from WPP in one of the biggest pay packages ever awarded to a FTSE 100 chief...

  2. April 28, 2016

    Investors rise up in day of protest over UK executive pay

    Shareholders rose up against the pay of Britain’s bosses on Thursday in the most dramatic day of protests against chief...

  3. Fast FT

    April 28, 2016

    AbbVie to acquire Stemcentrx in $5.8bn deal

    The pharmaceuticals M&A merry-go-round has started spinning fast again. In one of several deals announced on Thursday,...

  4. Fast FT

    April 28, 2016

    Opening Quote: pay day moans; profits slump for Lloyds; Mars mission

    Five large companies are expected to suffer big executive pay moans from shareholders today, Lloyds’ bank profits are...

  5. FT Alphaville

    April 28, 2016

    FT Opening Quote

    Five large companies are expected to suffer big executive pay moans from shareholders today, Lloyds’ bank profits are...

  6. April 28, 2016

    Shareholder pay revolt set to heat up

    Shareholders are preparing for potential rebellions over executive pay at four big UK listed companies on Thursday as...

  7. Fast FT

    April 25, 2016

    Opening Quote: BHS blues, Rexam and Snoozebox

    BHS is sliding into administration, Rexam‘s takeover is almost in the can, Snoozebox‘s CEO has quit. FT Opening Quote,...

  8. April 19, 2016

    The secret of a world-class biotech sector

    Britain, it is often said, has world-class science but too few world-class science-based companies. Nowhere is this...

  9. April 5, 2016

    Hedge funds knocked by Allergan’s fall

    Four of the US’s largest hedge funds saw as much as $900m knocked off the value of their holdings in Allergan when new...

  10. April 5, 2016

    Shire falls on fear tougher US tax code could hurt Baxalta deal

    Shire’s shares fell on Tuesday amid concerns that a tougher US tax code may unravel some of the benefits of its $32bn...

  11. March 21, 2016

    Shire spurts higher in short-squeeze talk

    Talk of a short squeeze helped Shire push to the top of the FTSE 100 risers on Monday. The drugmaker climbed 4.1 per...

  12. February 26, 2016

    Tate & Lyle trio swoops as price falls

    Buying stock at what appears to be a trough in a company’s share price is a tough thing to do, but senior management at...

  13. February 11, 2016

    Shire calls halt to $50bn acquisition spree

    Shire has called a halt to the $50bn acquisition spree that has transformed the London-listed drugmaker over the past...

  14. Fast FT

    February 11, 2016

    Shire confident of 'strong results' this year

    Shire, fresh from its $32bn takeover of Baxalta last month, has announced better-than-expected full-year results and...

  15. Fast FT

    January 27, 2016

    HSBC pinpoints juicy nuggets in Shire's $32bn deal

    HSBC’s pharmaceuticals analysts have been doing some trawling through SEC filings. Shares in Shire, the UK-listed but...

  16. January 15, 2016

    Shire deal demonstrates Kilsby’s M&A acumen

    Mastering the art of dealmaking has been a life-long pursuit for Susan Kilsby, the 57-year-old chairman of UK drugmaker...

  17. January 11, 2016

    Shire chief’s biggest task is to make deal pay off

    Shire’s $32bn takeover of Baxalta caps the company’s transformation from a specialist in pills for teenagers with...

  18. January 11, 2016

    Shire / Baxalta: unpopular exuberance

    Shire thinks that buying Baxalta is going to make it grow faster. Not in the usual sense of offering faster-growing...

  19. January 11, 2016

    Shire agrees $32bn takeover of Baxalta

    Shire has agreed a $32bn takeover of Baxalta in a sign that the two-year-old boom in pharmaceuticals mergers and...

  20. Fast FT

    January 11, 2016

    Shire struggling at the bottom of the FTSE 100

    Is Shire over-paying for Baxalta? Shares in the UK-listed pharmaceuticals company are dropping 6 per cent as...

  21. January 11, 2016

    What $32bn deal for Baxalta means to Shire

    Shire’s agreement to buy Baxalta for $32bn marks the biggest deal in the 30-year history of the UK-listed company and...

  22. Fast FT

    January 11, 2016

    Shire up 2.5% and Baxalta up 6% on $32bn deal

    Shares in Shire and Baxalta have both jumped after the UK pharmaceutical group agreed a $32bn deal for the US...

  23. Fast FT

    January 11, 2016

    Shire bags Baxalta in deal worth $32bn

    UK pharmaceutical group Shire has agreed to buy US drug-maker Baxalta in a deal worth $32bn. The deal, which has been...

  24. January 6, 2016

    Shire deal hinges on Baxalta tax status

    Shire’s potential $32bn takeover of Baxalta is dependent on whether the UK-listed drugmaker can pay for a large part of...

  25. January 6, 2016

    Mayfieldmania does not make John Lewis a model for quoted companies

    When the great pianist Franz Liszt played, audiences swooned. It’s the same with Sir Charlie Mayfield, chief executive...

  26. January 5, 2016

    Shire/Baxalta: how to eat your words

    Many chief executives would have stuck to standard blather about the offer “substantially undervaluing” his company....

  27. January 4, 2016

    Baxalta agrees $1.6bn deal for Symphogen cancer drug tie-up

    Baxalta, the US biotech company facing renewed takeover interest from Shire, has agreed a deal worth up to $1.6bn to...

  28. December 22, 2015

    Baxalta sounds out rivals as it weighs up Shire deal

    Baxalta is sounding out potential alternatives to a takeover by Shire even as the US biotech company remains open to a...

  29. December 2, 2015

    Shire leads drug stocks sector on FTSE

    Drugmakers were the preferred sector on Wednesday as the FTSE 100 rose to a one-month high. Shire gained 2.4 per cent...

  30. November 2, 2015

    Shire / Dyax: mother of pearls

    Flemming Ornskov, the chief executive of pharma group Shire, describes his acquisition strategy as a “string of pearls”...

  31. November 2, 2015

    Shire to buy US biotech group Dyax for $5.9bn

    Shire, the acquisitive London-listed drugmaker, has struck a defensive $5.9bn deal to buy Dyax, a US biotech company...

  32. October 23, 2015

    Shire eyes alternatives amid pursuit of Baxalta

    Shire, the London-listed drugmaker, is still committed to its $30bn bid for Baxalta but the company is looking at other...

  33. October 19, 2015

    Anglo American slides on De Beers downturn fears

    Anglo American was Monday’s sharpest FTSE 100 faller on worries that its balance sheet strength will be tested by a...

  34. September 28, 2015

    Orphan drugs become big business

    Orphan drugs might target small groups of patients, but they are increasingly big business. Pharmaceutical companies,...

  35. August 21, 2015

    FTSE 100’s worst losing streak in four years

    Drugs manufacturer Shire led London’s main index lower on Friday, but its move into correction territory this week was...

  36. August 16, 2015

    Shire steps up pressure on Baxalta to break takeover deadlock

    Shire is stepping up pressure on Baxalta to open its books before the UK-listed drugmaker will consider making a higher...

  37. August 13, 2015

    US regional banks benefit in absentia

    Europeans setting out to discover the States head for New York, Boston or San Francisco. But latter-day De Tocquevilles...

  38. August 10, 2015

    Baxalta chief denounces Shire’s ‘lowball’ offer

    Baxalta has doubled down on its opposition to a $30bn hostile takeover approach from Shire, describing the...

Search for Shire PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on why tax inversions are losing their appeal...
    October 15, 2014

    Lex on why tax inversions are losing their appeal